PharVision Advisers’s Shift4 FOUR Stock Holding History

PharVision Advisers’s Portfolio FOUR Stock Details FOUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,035	Closed	-$235K	–	792
2025 Q3	$235K	Buy	+3,035	New	+$282K	0.13%	375

Other funds holding FOUR

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DPCM

Darlington Partners Capital Management Greenbrae, California $2.23B AUM 16.2% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PharVision Advisers's FOUR Position: Q4 2025 in Review

PharVision Advisers sold out of Shift4 (FOUR) in Q4 2025, closing a stake of 3,035 shares — an estimated $235K sold.

PharVision Advisers first reported a position in FOUR in Q3 2025 and held it in 1 quarter. The position peaked at $235K in Q3 2025. 402 funds tracked by Wall St. Rank hold FOUR as of Q4 2025.

PharVision Advisers reported no remaining Shift4 position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 3,035 Shift4 shares in Q4 2025, an estimated $235K.
PharVision Advisers first reported a position in Shift4 in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Shift4 position peaked at $235K in Q3 2025.
402 funds tracked by Wall St. Rank held Shift4 as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.